Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.

Yokoi F, Gründer G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF.

Neuropsychopharmacology. 2002 Aug;27(2):248-59.

2.
3.

Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.

Baumhackl U, Bizière K, Fischbach R, Geretsegger C, Hebenstreit G, Radmayr E, Stabl M.

Br J Psychiatry Suppl. 1989 Oct;(6):78-83.

PMID:
2695130
4.

Cholinomimetic activities of minaprine.

Worms P, Kan JP, Steinberg R, Terranova JP, Perio A, Biziere K.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):411-8.

PMID:
2586634
5.

Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist.

Schumacher C, Steinberg R, Kan JP, Michaud JC, Bourguignon JJ, Wermuth CG, Feltz P, Worms P, Biziere K.

Eur J Pharmacol. 1989 Jul 18;166(2):139-47.

PMID:
2792188
6.

Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat.

Santucci V, Fournier M, Worms P, Keane P, Bizière K.

Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):93-100.

PMID:
2571947
7.

3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activities.

Wermuth CG, Schlewer G, Bourguignon JJ, Maghioros G, Bouchet MJ, Moire C, Kan JP, Worms P, Biziere K.

J Med Chem. 1989 Mar;32(3):528-37.

PMID:
2563772
8.

Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.

Stabl M, Biziére K, Schmid-Burgk W, Amrein R.

J Neural Transm Suppl. 1989;28:77-89. Review.

PMID:
2677244
9.

Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants.

Simiand J, Keane PE, Biziere K, Soubrie P.

Arch Int Pharmacodyn Ther. 1989 Jan-Feb;297:272-85.

PMID:
2567153
10.

Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants.

Perio A, Terranova JP, Worms P, Bluthe RM, Dantzer R, Biziere K.

Psychopharmacology (Berl). 1989;97(2):262-8.

PMID:
2567026
11.

Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.

Renoux G, Bizière K, Renoux M, Steinberg R, Kan JP, Guillaumin JM.

Life Sci. 1989;44(12):771-7.

PMID:
2539542
13.
15.

Characterization of the scopolamine stimulus in rats.

Jung M, Perio A, Worms P, Biziere K.

Psychopharmacology (Berl). 1988;95(2):195-9.

PMID:
3137597
16.

Brain neocortex and imuthiol regulate the expression of MHC antigens on mouse T lymphocytes.

Renoux G, Renoux M, Bizière K.

Immunopharmacol Immunotoxicol. 1988;10(2):219-29.

PMID:
2844880
17.

The sensitivity of gamma-aminobutyric acid antagonists to thiocyanate is related to the absence of a functional anionic group in their structure.

Wermuth CG, Chambon JP, Heaulme M, Melikian A, Schlewer G, Leyris R, Biziére K.

Eur J Pharmacol. 1987 Dec 15;144(3):375-8.

PMID:
2831069
18.

The effects of general anaesthetics on GABAergic synaptic transmission.

Keane PE, Biziere K.

Life Sci. 1987 Sep 21;41(12):1437-48. Review. No abstract available.

PMID:
2887996
19.

Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.

Jung M, Perio A, Terranova JP, Worms P, Biziere K.

Eur J Pharmacol. 1987 Jul 2;139(1):111-6.

PMID:
3653237
20.
21.

Characterization of the binding of [3H]SR 95531, a GABAA antagonist, to rat brain membranes.

Heaulme M, Chambon JP, Leyris R, Wermuth CG, Biziere K.

J Neurochem. 1987 Jun;48(6):1677-86.

PMID:
3033146
22.

Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.

Bohacek N, Ravic M, Bizière K.

Drugs Exp Clin Res. 1987;13(7):435-42.

PMID:
3308390
23.

[Animal models of epilepsy and experimental seizures].

Bizière K, Chambon JP.

Rev Neurol (Paris). 1987;143(5):329-40. Review. French.

PMID:
3116633
24.

SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.

Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.

J Pharmacol Exp Ther. 1987 Jan;240(1):251-8.

PMID:
3100771
25.

SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.

Worms P, Kan JP, Wermuth CG, Roncucci R, Bizière K.

J Pharmacol Exp Ther. 1987 Jan;240(1):241-50.

PMID:
3100770
26.

Consequences of bilateral brain neocortical ablation on imuthiol-induced immunostimulation in mice.

Renoux G, Biziere K, Renoux M, Bardos P, Degenne D.

Ann N Y Acad Sci. 1987;496:346-53. No abstract available.

PMID:
3037975
27.

A 7-phenyl substituted triazolopyridazine has inverse agonist activity at the benzodiazepine receptor site.

Biziere K, Bourguignon JJ, Chambon JP, Heaulme M, Perio A, Tebib S, Wermuth CG.

Br J Pharmacol. 1987 Jan;90(1):183-90.

28.

Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice.

Worms P, Biziere K.

Psychopharmacology (Berl). 1987;93(4):489-93.

PMID:
2893415
31.

Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.

Worms P, Kan JP, Wermuth CG, Biziere K.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):246-52.

PMID:
3100965
32.

Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.

Perio A, Chambon JP, Calassi R, Heaulme M, Biziere K.

J Pharmacol Exp Ther. 1986 Nov;239(2):542-7.

PMID:
3095540
33.

Specific binding of a phenyl-pyridazinium derivative endowed with GABAA receptor antagonist activity to rat brain.

Heaulme M, Chambon JP, Leyris R, Wermuth CG, Biziere K.

Neuropharmacology. 1986 Nov;25(11):1279-83.

PMID:
3025766
34.

Interactions between three pyridazinyl-GABA derivatives and central GABA and glycine receptors in the rat, an in vivo microiontophoretic study.

Michaud JC, Mienville JM, Chambon JP, Bizière K.

Neuropharmacology. 1986 Nov;25(11):1197-203.

PMID:
3025764
35.

Biochemical characterization of the interaction of three pyridazinyl-GABA derivatives with the GABAA receptor site.

Heaulme M, Chambon JP, Leyris R, Molimard JC, Wermuth CG, Biziere K.

Brain Res. 1986 Oct 8;384(2):224-31.

PMID:
3022866
36.

A double-blind comparison of minaprine and imipramine in the treatment of depressed patients.

Bohacek N, Ravic M, Bizière K.

J Clin Psychopharmacol. 1986 Oct;6(5):320-1. No abstract available.

PMID:
3771821
37.

In vivo voltammetric monitoring of catecholamine metabolism in the A1 and A2 regions of the rat medulla oblongata.

Suaud-Chagny MF, Steinberg R, Mermet C, Biziere K, Gonon F.

J Neurochem. 1986 Oct;47(4):1141-7.

PMID:
3091764
38.

Quantitative electroencephalographic profile of 3-(4-hydroxy-1-piperidinyl)-6-(2,4-dichlorophenyl)-pyridazine (SR 41378) in the rat.

Santucci V, Rocher D, Veyrun J, Bizière K.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):186-9.

PMID:
2875399
39.

[Pharmacologic profile of an original psychotropic drug. Minaprine: comparison with six reference antidepressives].

Worms P, Kan JP, Perio A, Wermuth CG, Bizière K, Roncucci R.

J Pharmacol. 1986 Apr-Jun;17(2):126-38. French.

PMID:
3489135
40.

Effect of the antidepressant minaprine on both forms of monoamine oxidase in the rat.

Kan JP, Mouget-Goniot C, Worms P, Biziere K.

Biochem Pharmacol. 1986 Mar 15;35(6):973-8.

PMID:
3954800
41.

Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.

Worms P, Martinez J, Briet C, Castro B, Biziere K.

Eur J Pharmacol. 1986 Mar 4;121(3):395-401.

PMID:
3699101
42.

Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.

Hallot A, Brodin R, Merlier J, Brochard J, Chambon JP, Biziere K.

J Med Chem. 1986 Mar;29(3):369-75.

PMID:
3950916
43.

Interactions between the neocortex and lymphocytes.

Bizière K, Renoux G.

Clin Neuropharmacol. 1986;9 Suppl 4:362-4. No abstract available.

PMID:
3494511
44.

Absence of modifications in gamma-aminobutyric acid metabolism after repeated generalized seizures in amygdala-kindled rats.

Lerner-Natoli M, Heaulme M, Leyris R, Biziere K, Rondouin G.

Neurosci Lett. 1985 Dec 4;62(2):271-6.

PMID:
4088536
45.

Electroencephalographic study of SR 95103, a GABAA antagonist: interaction with inhibitory amino acids and muscimol.

Santucci V, Fournier M, Chambon JP, Biziere K.

Eur J Pharmacol. 1985 Aug 15;114(2):219-22.

PMID:
2995080
46.

CM 40907: a structurally novel anticonvulsant in mice, rats and baboons.

Chambon JP, Brochard J, Hallot A, Heaulme M, Brodin R, Roncucci R, Biziere K.

J Pharmacol Exp Ther. 1985 Jun;233(3):836-44.

PMID:
2989499
47.

Minaprine for senile dementia.

Passeri M, Cucinotta D, de Mello M, Storchi G, Roncucci R, Bizière K.

Lancet. 1985 Apr 6;1(8432):824. No abstract available.

PMID:
2858705
48.

An arylaminopyridazine derivative of gamma-aminobutyric acid (GABA) is a selective and competitive antagonist at the GABAA receptor site.

Chambon JP, Feltz P, Heaulme M, Restle S, Schlichter R, Biziere K, Wermuth CG.

Proc Natl Acad Sci U S A. 1985 Mar;82(6):1832-6.

49.

EEG effects of i.v. infusion of pentylenetetrazol in rats: a model for screening and classifying antiepileptic compounds.

Santucci V, Fournier M, Keane P, Simiand J, Michaud JC, Morre M, Biziere K.

Psychopharmacology (Berl). 1985;87(3):337-43.

PMID:
3936090
50.

Minaprine, a new drug with antidepressant properties.

Bizière K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R.

Drugs Exp Clin Res. 1985;11(12):831-40.

PMID:
3836113

Supplemental Content

Loading ...
Support Center